Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Neoplasms and PDCD1LG2[original query] |
|---|
| Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias. Genes, chromosomes & cancer 2014 Jul 53 (7): 579-88. Sarhadi Virinder Kaur, Lahti Leo, Scheinin Ilari, Ellonen Pekka, Kettunen Eeva, Serra Massimo, Scotlandi Katia, Picci Piero, Knuutila Saka |
| Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer. Cancer immunology research 2017 10 5 (11): 1046-1055. Masugi Yohei, Nishihara Reiko, Hamada Tsuyoshi, Song Mingyang, da Silva Annacarolina, Kosumi Keisuke, Gu Mancang, Shi Yan, Li Wanwan, Liu Li, Nevo Daniel, Inamura Kentaro, Cao Yin, Liao Xiaoyun, Nosho Katsuhiko, Chan Andrew T, Giannakis Marios, Bass Adam J, Hodi F Stephen, Freeman Gordon J, Rodig Scott J, Fuchs Charles S, Qian Zhi Rong, Nowak Jonathan A, Ogino Shu |
| Integrated genomic and molecular characterization of cervical cancer. Nature 2017 1 543 (7645): 378-384. , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy. European journal of cancer (Oxford, England : 1990) 2018 05 94 179-186. Gatalica Zoran, Xiu Joanne, Swensen Jeff, Vranic Sem |
| Immune profiles in primary squamous cell carcinoma of the head and neck. Oral oncology 2019 8 96 77-88. Saloura Vassiliki, Izumchenko Evgeny, Zuo Zhixiang, Bao Riyue, Korzinkin Michael, Ozerov Ivan, Zhavoronkov Alex, Sidransky David, Bedi Atul, Hoque Mohammad O, Koeppen Hartmut, Keck Michaela K, Khattri Arun, London Nyall, Kotlov Nikita, Fatima Aiman, Vougiouklakis Theodore, Nakamura Yusuke, Lingen Mark, Agrawal Nishant, Savage Peter A, Kron Stephen, Kline Justin, Kowanetz Marcin, Seiwert Tanguy |
| TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer. Therapeutic advances in medical oncology 2021 8 13 17588359211038477. Li Teng, Wang Han, Xu Jiachen, Li Chengcheng, Zhang Yudong, Wang Guoqiang, Liu Yutao, Cai Shangli, Fang Wenfeng, Li Junling, Wang Zhij |
| Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers. Frontiers in oncology 2021 11 753788. Liang Sheng-Kai, Chien Li-Hsin, Chang Gee-Chen, Tsai Ying-Huang, Su Wu-Chou, Chen Yuh-Min, Huang Ming-Shyan, Lin Hsien-Chih, Fang Wen-Tsen, Hung Hsiao-Han, Jiang Shih-Sheng, Chen Chih-Yi, Chen Kuan-Yu, Chang I-Shou, Hsiung Chao A, Chen Chien-Jen, Yang Pan-Chyr, |
| Identification of Metabolism-Related Gene-Based Subgroup in Prostate Cancer. Frontiers in oncology 2022 12 909066. Yu Guopeng, Liang Bo, Yin Keneng, Zhan Ming, Gu Xin, Wang Jiangyi, Song Shangqing, Liu Yushan, Yang Qing, Ji Tianhai, Xu B |
| Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer. Disease markers 2022 3 2022 5621441. Lv Ji, Ren Jia, Zheng Jie, Zhang Fuliang, Han Me |
| FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis. Medicine 2023 9 102 (37): e35084. Zhimin Sun, Xiaoli Sun, Yaqin Yuan, Hongsheng Li, Xiaona Li, Zhigang Y |
| SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients. Discover. Oncology 2023 6 14 (1): 89. Ran Zeng, Xiaoyun Fan, Jin Yang, Chen Fang, Jieyi Li, Wei Wen, Jing Liu, Mengchen Lv, Xiangran Feng, XiaoKai Zhao, Hongjie Yu, Yuhuan Zhang, Xianwen Sun, Zhiyao Bao, Jun Zhou, Lei Ni, Xiaofei Wang, Qijian Cheng, Beili Gao, Ziying Gong, Daoyun Zhang, Yuchao Dong, Yi Xia |
| Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Frontiers in molecular biosciences 2023 2 10 963639. Huang Wei, Wu Yuliang, Zhu Jihui, Luo Ning, Wang Chunyan, Liu Shupeng, Cheng Zhongpi |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
| Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification. Scientific reports 2024 5 14 (1): 11278. Miseon Lee, Tae-Kyung Yoo, Byung Joo Chae, Ahwon Lee, Yoon Jin Cha, Jieun Lee, Sung Gwe Ahn, Jun Ka |
| A study of the association of vitamin D receptor (VDR) as a predictive biomarker for immune checkpoint inhibitor therapy with immune invasion in colon adenocarcinoma. Journal of pharmaceutical and biomedical analysis 2024 10 252 116510. Guanqun Chao, Ailing Lin, Yang B |
- Page last reviewed:Feb 1, 2024
- Content source: